Skip to content
Home/Companies/MedTech/SAGA Dx

SAGA Dx

MedTech·Sweden·Exited 2026·Held 5yr
Entry
2021
Hold
5yr
Exit
2026

Who owns SAGA Dx?

SAGA Dx was owned by Segulah Medical Acceleration through Segulah Medical Acceleration (2021 vintage) from 2021 to 2026, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-17

Segulah Medical Acceleration
Investor
Segulah Medical Acceleration
Segulah Medical Acceleration · 2021 · Life Sciences VC

Key facts

HQSweden
SectorMedTech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2026

More from Segulah Medical Acceleration

Other portfolio companies in the same fund.

Basic Genomics
Active
BiotechSweden· 2025
Protembis
Protembis
Active
MedTechGermany· 2024
Collective Minds Radiology
Active
HealthTechSweden· 2023
Senzime
Active
MedTechSweden· 2023
Navinci Diagnostics
Active
BiotechSweden· 2022
CytaCoat
Active
MedTechSweden· 2021

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track SAGA Dx

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy SAGA Dx?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on SAGA Dx.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue